Introduction {#Sec1}
============

Multimodality imaging represents an area of very rapid growth with important professional implications. It may be anticipated that combined functional and anatomical imaging with positron emission tomography (PET)/computed tomography (CT), single-photon emission computed tomography (SPECT)/CT and even PET/magnetic resonance imaging will play a central part in diagnostic imaging of the near future. In 2007, the European Society of Radiology and the European Association of Nuclear Medicine published a document entitled "White Paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on Multimodality Imaging" \[[@CR1], [@CR2]\]. This paper sets out the positions and aspirations of ESR and EANM to work together on an equal and constructive basis for the future benefit of both specialties on which to build. To provide a database for these efforts, ESR and EANM performed a survey among the individual memberships of both societies. The aim was to obtain information on the status of multimodality imaging equipment and procedures throughout Europe, and to identify any future visions on training for combined modalities amongst respondents.

Methods {#Sec2}
=======

A questionnaire was forwarded to all individual members of ESR and EANM. The questions posed included: (1) aspects of current practice procedures and equipment at the individual respondent's facility and (2) vision on cooperative interdisciplinary training for the future. The questionnaire structure is reported in the [Appendix](#Sec6){ref-type="sec"}.

Results {#Sec3}
=======

A total of 1,841 replies were received: 1,491 from ESR members (from 38 European countries) and 350 from EANM members (from 39 countries). The answers to the questionnaires formed the basis of the currently reported analysis. The respondents by country and age group are reported in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, respectively. The reporting (Fig. [1](#Fig1){ref-type="fig"}) and the billing (Fig. [2](#Fig2){ref-type="fig"}) of multimodality imaging studies are very heterogeneous. The part of CT in a PET/CT examination conducted as a full diagnostic CT with or without intravenous contrast enhancement is presently the practice in a relatively small number of facilities (Fig. [3](#Fig3){ref-type="fig"}). The majority of respondents of both societies believe that the proportion of PET/CT conducted as a full diagnostic CT examination, employing intravenous contrast enhancement will increase over time (Fig. [4](#Fig4){ref-type="fig"}). As expected, oncology is the most common indication for PET or PET/CT (Fig. [5](#Fig5){ref-type="fig"}), and 18F-FDG is the most used PET tracer for clinical applications (Table [3](#Tab3){ref-type="table"}). The large majority of the respondents of both societies were in favour of an interdisciplinary training programme, being developed on a European level together by ESR and EANM and the respective sections of the European Union of Medical Specialists (Fig. [6](#Fig6){ref-type="fig"}). The majority (65%) of ESR members in favour of the principle of the interdisciplinary training programme indicated incorporated training in nuclear medicine and radiology as their preferred option (Fig. [7](#Fig7){ref-type="fig"}). The remaining 35% favoured an adjusted period of training in the other specialty in addition to full training in the primary specialty. Among the EANM members in favour of an interdisciplinary training programme, 50% indicated as preferred option an adjusted period of training, and 50% an incorporated training in nuclear medicine and radiology taking the form of a cross-over or integrated training programme (Fig. [7](#Fig7){ref-type="fig"}). Table 1Respondents by country.ESREANMCountryNumberCountryNumberItaly219France40Germany179Italy32Spain158The Netherlands26United Kingdom89Germany24France74Turkey21The Netherlands64Belgium16Austria57Spain13Belgium52United Kingdom12Poland51Greece11Greece50Portugal9Others498Others146Total1,491Total350Table 2Respondents by age group.Age group (years)ESR (n = 1,491)EANM (n = 350)21--308%3%31--4030%23%41--5032%38%51--6023%24%61+7%12%Fig. 1Answers to question 1 of the survey, "In your facility, PET/CT results are reported by..."Fig. 2Answers to question 2 of the survey, "In your facility, PET/CT results are billed by..."Fig. 3Answers to question 3 of the survey, "How often is the CT part of PET/CT conducted as a full diagnostic CT+/− contrast enhancement in your facility?"Fig. 4Answers to question 4 of the survey, "Do you think that the proportion of diagnostic CT+/− contrast enhancement will...?"Fig. 5Answers to question 5 of the survey, "Does your facility undertake PET or PET/CT in the following indications?"Table 3Answers to question 6 of the survey: radiopharmaceuticals in clinical use in European countries.ESREANM^18^F-Fluoro-2-deoxy-D-glucose (FDG)73%99%^18^F-Dopa10%29%^18^F-Fluorocholine10%23%^18^F-Fluoroethyl-L-tyrosine (FET)5%12%^18^F-Fluorothymidine (FLT)4%14%Other ^18^F4%12%Any ^11^C2%14%Rubidium-821%6%15O-Water1%11%Others7%13%Fig. 6Answers to question 6 of the survey, "Which of the following radiopharmaceuticals are in clinical use in your country?"Fig. 7Answers to question 7 of the survey, "Would you be in favour of an interdisciplinary training programme being developed on a European level together by ESR and EANM and the respective UEMS sections?"

Discussion {#Sec4}
==========

The main purpose of this survey was to collect information on the practice of multimodality imaging in Europe among the individual memberships of ESR and EANM. It sought to address regulatory and supervisory issues, the training requirements applicable and the comparative roles of radiologists and nuclear medicine physicians in the various jurisdictions surveyed.

The general limitations of a pan-European questionnaire must be taken into account when interpreting the results. This is particularly so when respondents are chosen from two independent and fully functioning disciplines as is the case in this effort. Amongst other factors the questionnaire value is dependent upon question validity and lack of ambivalence, and on the care used and bias of respondents. A certain amount of the reported data may thus not be representative, but alternative methods of gathering information in such a context are difficult, laborious and not practicable.

The majority of the members of ESR and EANM believe that the proportion of PET/CT conducted as a full diagnostic CT with contrast enhancement will increase in the future. Substantive training in both radiology and nuclear medicine is a prerequisite for high-quality examination interpretation with hybrid systems. There are several ways to achieve such training, and appropriation of "dual training" structures will differ between countries relating to differences in infrastructure and legislation \[[@CR1], [@CR2]\]. In addition to being structured and comprehensive, training should be conducted in accredited training centres. It should incorporate the principles and major modalities of both specialties to allow the trainee to learn the appropriate place of PET-SPECT/CT in the overall investigative algorithm.

Conclusion {#Sec5}
==========

The overall findings of this survey show that there is a wide heterogeneity in the use and practice of multimodality imaging in Europe. This situation may well limit the application of the technique with its full clinical potential. As clearly indicated by the results of the present survey, the large majority of respondents of both societies were in favour of an interdisciplinary training programme, being developed on a European level together by ESR and EANM and the respective sections of the European Union of Medical Specialists.

This paper from the ESR and the EANM was prepared by Drs A. Cuocolo and E. Breatnach. It is being published concurrently in the European Journal of Nuclear Medicine and Molecular Imaging Multimodality imaging in Europe: a survey by the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR). Cuocolo A, Breatnach E. Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):163--7.

Appendix {#Sec6}
========

Survey questions In your facility, PET/CT results are reported by PET by a nuclear medicine specialist, CT by a radiologistA nuclear medicine physicianA radiologistA dual specialistOtherIn your facility, PET/CT results are billed by PET by a nuclear medicine physician, CT by a radiologistA nuclear medicine physicianA radiologistA dual specialistOtherHow often is the CT part of PET/CT conducted as a full diagnostic CT+/− contrast enhancement in your facility? Never\<20%20--40%40--60%60--80%\>80%Do you think that the proportion of diagnostic CT+/− contrast enhancement will IncreaseRemain the sameDecreaseDoes your facility undertake PET or PET/CT in the following indications? OncologyCardiologyNeurologyInfection/inflammationOthersWhich of the following radiopharmaceuticals are in clinical use in your country? 18F-FDG18F-Dopa18F-Fluorocholine18F-FET18F-FLTOther 18FAny 11CRubidium-8215O-WaterOthersWould you be in favour of an interdisciplinary training programme being developed on a European level together by ESR and EANM and the respective UEMS sections? Yes Adjusted period of training in the other speciality in addition to full training in the primary specialityIntegrated training programme: an incorporated training in nuclear medicine and radiology taking the form of a cross-over or integrated training programmeNo
